← Back to Search

Procedure

Ductoscopic papillectomy for Intraductal Papilloma

N/A
Waitlist Available
Led By Sheldon Feldman, MD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights

Study Summary

This trial is for patients with Pathologic nipple discharge who will be diagnosed with a solitary papilloma within the discharging duct. The investigators will attempt to remove the papilloma using the ductoscopic basket. Histopathological evaluation will be performed to confirm the ductoscopic diagnosis and to determine the existence of any malignant tissue.

Eligible Conditions
  • Breast Infection
  • Intraductal Papilloma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Complete Ductoscopic Retrievals
Secondary outcome measures
Number of Patients With Cessation of Nipple Discharge
Number of Patients With Clinical Recurrence of Nipple Discharge

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ductoscopic papillectomyExperimental Treatment1 Intervention
Ductoscopic papillectomy to treat pathological nipple discharge

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterLead Sponsor
441 Previous Clinical Trials
582,187 Total Patients Enrolled
Columbia UniversityOTHER
1,431 Previous Clinical Trials
2,460,824 Total Patients Enrolled
Sheldon Feldman, MDPrincipal InvestigatorMontefiore Medical Center
2 Previous Clinical Trials
23 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to join this medical experiment?

"Per the clinicaltrials.gov records, this research program is not presently accepting new participants; it was initially posted on September 27th 2013 and most recently updated July 28th 2022. However, there are 58 other related studies actively recruiting right now."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Feasibility and Therapeutic Efficacy of Ductoscopic Papilloma Extraction in Patients With Pathologic Nipple Discharge
Sheldon Feldman 2013. "Feasibility and Therapeutic Efficacy of Ductoscopic Papilloma Extraction in Patients With Pathologic Nipple Discharge". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01901562.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top